The results showed that A172 and U373 highly expressed DAB2IP, whereas other GBM cell lines, including LN18, LN229, U87MG, and U251, lost DAB2IP expression (Fig. 1A, B). The gene discussed is DAB2IP; the disease is glioblastoma.